Position in LFCR
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$740
-$41 QoQ
Shares Held
141
-32.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#88
of 98 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LFCR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FIFTH THIRD BANCORP holds $131,747,740 across 34 Drug Manufacturers - Specialty & Generic names. LFCR ranks #31 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
158,184 | $85,708,836 | |
| 2 | ZTS |
Zoetis Inc.
|
112,370 | $8,074,908 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
288,888 | $7,109,533 | |
| 4 | VTRS |
Viatris Inc
|
411,537 | $6,535,207 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
30,217 | $5,092,773 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
59,330 | $2,804,529 | |
| 7 | LQDA |
Liquidia Corp
|
35,159 | $2,803,227 | |
| 8 | HLN |
Haleon plc
|
217,576 | $2,029,984 |
All Filings in LFCR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $740 | 141 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $781 | 210 | Shares | Defined | 2026-05-01 | |
| 2025-12-31 | $1,071 | 131 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $964 | 131 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $1,364 | 168 | Shares | Defined | 2025-07-15 | |
| 2025-03-31 | $471 | 67 | Shares | Defined | 2025-04-15 | |
| 2024-12-31 | $965 | 130 | Shares | Defined | 2025-01-21 | |
| 2024-09-30 | $1,084 | 220 | Shares | Defined | 2024-10-17 | |
| 2020-06-30 | $7,960 | 1,000 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $8,690 | 1,000 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||